Keynote-158 study, FDA granted accelerated approval of pembrolizumab for the treatment of patients with advanced PD-L1-positive cervical cancer
@article{ATM46503, author = {Edith Borcoman and Christophe Le Tourneau}, title = {Keynote-158 study, FDA granted accelerated approval of pembrolizumab for the treatment of patients with advanced PD-L1-positive cervical cancer}, journal = {Annals of Translational Medicine}, volume = {8}, number = {23}, year = {2020}, keywords = {}, abstract = {}, issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/46503} }